Johnson & Johnson Start Phase 1 Clinical Trial of Ebola Vaccine

by Dr. Trupti Shirole on  January 7, 2015 at 12:53 PM Clinical Trials News
RSS Email Print This Page Comment bookmark
Font : A-A+

US pharmaceutical giant Johnson & Johnson has started human trials on a possible vaccine against Ebola. The company is hoping to move on to studies on large groups of patients by April.
 Johnson & Johnson Start Phase 1 Clinical Trial of Ebola Vaccine
Johnson & Johnson Start Phase 1 Clinical Trial of Ebola Vaccine

The Oxford Vaccine Group at Britain's Oxford University is carrying out Phase I testing of the Ebola vaccine. 72 healthy volunteers are part of the test that will examine how their bodies tolerate the potential vaccine.

Johnson & Johnson said, "At the end of October we would spend up to $200 million to speed up and expand our Ebola vaccine program. We have already produced more than 400,000 doses, and two million courses will be ready by the year end. If necessary we can make five million doses within 12 to 18 months."

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Clinical Trials Clinical Trials - The Past and The Future Clinical Trials - Different Phases of the trial Placebo Effects: Rare Insights Congo Fever Vaccination for Children Ebola Virus Disease 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive